Related Experiment Video
Updated: Jul 20, 2026

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
Published on: September 28, 2022
Using phage lytic enzymes to control pathogenic bacteria
1Rockefeller University, New York, NY 10021, USA. vaf@mail.rockefeller.edu
Abstract:
Our laboratory has developed phage lytic enzymes to prevent infection by specifically destroying disease bacteria on mucous membranes and in blood. Enzymes specific for S. pneumoniae and S. pyogenes have been developed to be used nasally and orally to control these organisms in environments such as hospitals and nursing homes to prevent or markedly reduce serious infections by these pathogens. In addition, a B. anthracis-specific enzyme was developed to kill the vegetative forms of these bacteria in the blood of infected individuals. In animal studies, >80% of mice colonized mucosally or infected intravenously with pathogenic bacteria were decolonized or survived after a single enzyme treatment delivered to the same site of colonization or infection.
Insights
Phage lytic enzymes effectively eliminate disease bacteria like Streptococcus pneumoniae and Bacillus anthracis. These novel enzymes show promise in preventing and treating serious infections in animal models.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Bacterial infections pose significant threats, particularly in healthcare settings.
- Traditional antimicrobial strategies face challenges like resistance.
- Phage lytic enzymes offer a targeted approach to bacterial destruction.
Purpose of the Study:
- To develop and evaluate phage lytic enzymes for combating specific bacterial pathogens.
- To assess the efficacy of these enzymes in preventing and treating infections on mucous membranes and in the bloodstream.
Main Methods:
- Development of specific phage lytic enzymes targeting Streptococcus pneumoniae, Streptococcus pyogenes, and Bacillus anthracis.
- Administration of enzymes via nasal, oral, or intravenous routes in animal models.
- Evaluation of decolonization and survival rates post-treatment.
Main Results:
- Enzymes targeting S. pneumoniae and S. pyogenes demonstrated efficacy for nasal and oral applications.
- A B. anthracis-specific enzyme effectively targeted vegetative forms in the blood.
- Over 80% of treated mice were decolonized or survived single-dose enzyme treatment.
Conclusions:
- Phage lytic enzymes represent a promising strategy for controlling specific bacterial infections.
- Targeted enzyme therapy can prevent serious infections in vulnerable populations and treat existing bacteremia.
- Further research may lead to novel antimicrobial therapies with high specificity and efficacy.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Biological Methods for Microbial Control
Viral Replication: Lytic Cycle
DNA Bacteriophages
Viral Replication: Lysogenic Cycle

